Discover Investigational New Animal Drugs (INADs) at Fish Hatchery Willow Beach, operated by the Aquatic Animal Drug Approval Partnership. This exclusive program focuses on obtaining FDA approval for crucial medications in fish culture and fisheries management. INADs provide legal access to a range of drugs and treatments under controlled conditions, benefiting fish culturists, biologists, and managers. Open to researchers, hatchery managers, private aquaculturists, and zoos, participation involves a $700 annual fee per INAD for non-USFWS facilities. Enroll through the INAD database, meeting validation requirements, and entering into a Cooperative Agreement. The program runs on a calendar year, facilitating crucial data collection for FDA approval. Connect with Paige Maskill and Bonnie Johnson for more details.